Paul Scott graduated with a BSc (Hons) in Medical Microbiology from The University of Edinburgh in 1997. He then studied for a PhD in Molecular Virology, titled: "A study of the genetic diversity of GB virus C as compared with Hepatitis C Virus", at Cranfield University, supervised by Prof. Jonathan Brown (Gloucestershire Royal Hospital NHS Trust). During these studies, he worked on genetic comparisons of Hepatitis C Virus and GB virus C to attempt to explain why GBV-C does not cause hepatitis, despite having a similar genetic structure to Hepatitis C Virus.
After completing his PhD, Paul gained HIV-1 genotypic resistance testing experience at PHLS Birmingham (supervised by Dr Deenan Pillay and Dr Patricia Cane), before becoming a post-doctoral researcher as part of a large Wellcome Trust funded project at The University of Birmingham/The University of Warwick with Dr Patricia Cane and Dr D James Nokes. This Post-Doctoral work involved studying the immunoepidemiology of respiratory syncytial virus in Kilifi District, Kenya, where he developed RT-PCR assays and ELISAs for implementation in Kenya. Following this, Paul continued his Post-Doctoral research career at The University of Warwick identifying novel viral agents that could be implicated in Porcine Multi-Systemic Weaning Syndrome (with Prof. Laura Green), before embarking on 4 years as a Post-Doctoral Research Fellow with Prof. Nigel Dimmock and Prof. Andrew Easton studying defective interfering influenza virus particles as a novel antiviral agent. After a brief period of training and practicing as a Secondary School Science teacher, Paul returned to research at The University of Warwick for a short project looking at improving lentiviral packaging vector transfection efficiency, using HIV-2 genes with Dr. Emma Anderson.
In 2014, Paul started his studies on the NHS Scientific Training Programme to become a HCPC Registered Clinical Scientist, specialising in Virology and antiviral resistance. As part of this, his work-based training was completed at Birmingham Heartlands Hospital (PHE Laboratory Birmingham) and his MSc was awarded from Queen Mary University of London in 2017.
Paul is also a member of the British HIV Association (BHIVA) and Health Infection Society (HIS).
Paul Joined Micropathology as a Clinical Scientist in September 2017.